SLC5A5 and neoplasm: The tumor micromilieu might also play a role in regulation of NIS function and/or NIS membrane targeting thereby affecting the efficacy of NIS gene therapy approaches, which however has not been explored so far after in vivo NIS gene delivery in clinically relevant preclinical tumor models [58].